Combined THC and CBD for OUD and Chronic Pain

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The primary objective of this phase 2 study is to investigate the therapeutic potential of orally administered combined delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in relieving both pain and cue-induced opioid craving in people with co-occurring opioid use disorder (OUD) and chronic pain who are undergoing methadone therapy.
Epistemonikos ID: 259ccc4c8f2dddebe04c105ddd89ad4ad3cc3baf
First added on: Sep 01, 2024